Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines
- 1 June 2006
- Vol. 24 (24) , 5158-5168
- https://doi.org/10.1016/j.vaccine.2006.04.008
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Preparing for the Next PandemicNew England Journal of Medicine, 2005
- Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeysVaccine, 2004
- Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administrationVaccine, 2000
- The Economic Impact of Pandemic Influenza in the United States: Priorities for InterventionEmerging Infectious Diseases, 1999
- To fuse or not to fuse: the effects of electrostatic interactions, hydrophobic forces, and structural amphiphilicity on protein-mediated membrane destabilizationAdvanced Drug Delivery Reviews, 1999
- Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 proteinVaccine, 1995
- Defensins promote fusion and lysis of negatively charged membranesProtein Science, 1993
- Antibody response to the M2 protein of influenza A virus expressed in insect cellsJournal of General Virology, 1993
- A molecular model for membrane fusion based on solution studies of an amphiphilic peptide from HIV gp41Protein Science, 1992
- Preparation and use of Liposomes in the Treatment of Microbial InfectionsCRC Critical Reviews in Microbiology, 1988